Intrinsiqq
Sotera Health Company logo

Sotera Health Company Quality Score

SHC

⊜ Compare
Quality57

Business quality is the primary weakness (avg 48/100). Growth is the relative bright spot.

Broad-market heuristics · Not a buy/sell signal

Valuation and growth

Earnings Multiple
60/100
27.3x

25–30x, paying a growth premium

Cash Flow Multiple
40/100
34.6x

Above 30x, cash flow yield is thin

Revenue Growth
70/100
5.2%

5–10% CAGR, steady but not exceptional

Cash Flow Growth
70/100
9.1%

5–10% CAGR, steady but not exceptional

Business Quality & Capital Allocation

Share Dilution
30/100
3.3%

Diluting 2–5%, watch for SBC

Margin Trend
100/100
+8.9pp

Expanded 3+pp, strong improvement

Capital Structure
0/100
$1.86B

Net debt/FCF of 13.8x, high leverage

2022
$395M
$2.03B
2023
$296M
$2.33B
2024
$277M
$2.35B
2025
$345M
$2.27B
TTM
$412M
$2.28B
CashDebt
Return on Capital
60/100
10.7%

10–15%, respectable returns

Customize WeightsPremiumUpgrade

Sotera Health (SHC) quality: score, margins and returns

Sotera Health (SHC) scores 57/100 on Intrinsiqq's quality score (a mixed business), a weighted blend of 8 metrics each scored 0 to 100, on 33.6% operating margins and 10.7% ROIC. Every metric is computed from SEC filings; this is analysis, not investment advice.

Frequently asked

Is Sotera Health (SHC) a high-quality business?+

Sotera Health scores 57 out of 100 on Intrinsiqq's quality score, a weighted blend of 8 metrics each scored 0 to 100, which rates it a mixed business on these measures. Recent figures include a 33.6% operating margin and a 10.7% return on invested capital. Quality and price are separate questions: even a great business can be a poor investment if you overpay, so read this score alongside the valuation. The metric-by-metric breakdown is on this scorecard.

What does Sotera Health's quality score measure?+

Intrinsiqq's quality score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, change in share count, and balance-sheet strength, each computed from SHC's SEC filings rather than opinion or sentiment. A higher score means a more durable, capital-efficient business; it is not a buy or sell signal. Open each metric on this page to see exactly where Sotera Health scores well and where it falls behind.

What is Sotera Health's return on invested capital (ROIC)?+

Sotera Health earns about 10.7% on its invested capital, which is solid. ROIC measures how much profit a company generates per dollar put to work; sustained ROIC above its cost of capital is one of the clearest signs of a real competitive moat. Compare it to SHC's margins and growth on this scorecard to judge durability.

How profitable is Sotera Health?+

Sotera Health runs an operating margin of about 33.6% and a net margin of about 14.1%. Revenue has grown at roughly 7.3% a year recently. High, stable margins usually point to pricing power and operating discipline. Margins are most telling next to growth and returns on capital, all of which feed this quality score. This is analysis from SEC filings, not investment advice.

How the market compares: US profitability statistics

SourceQuality score computed from the 10-Q filed 27 Oct 2026, covering the period ending 30 Sept 2026, as reported to the SEC. Data last refreshed 4 Nov 2026. How this is calculated.

Fiscal year ends Dec. Sector medians are approximate S&P 500 benchmarks and update periodically. Checks use broad-market heuristics, so sector norms may differ, and the valuation checks are more cyclical than the quality checks.

Peers

Services-Misc Health & Allied Services, NEC · Pick stocks to compare with SHC

CompareIntrinsic value
PGNYProgyny Inc.
$30.10+3.58%89
VMDViemed Healthcare Inc.
$10.11+6.93%82
QIPTQuipt Home Medical Corp.
No recent price11
AGLAgilon Health Inc.
$96.23+9.61%28
CONConcentra Group Holdings Inc.
$41.06+2.27%57
ACHCAcadia Healthcare Company, Inc.
$32.44+9.52%19
GHGuardant Health Inc.
$168.58-3.67%30
PNTGThe Pennant Group, Inc.
$44.04+6.92%54

Held by ETFs

SHC is in 74 US ETFs. The largest of them, with SHC's weight in each:

Spot a number that looks wrong? Check it in SHC's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing SHC

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.